Quiz 1 Flashcards

(284 cards)

1
Q

Abnormal growth of tissue resulting from uncontrolled progressive multiplication of cells that serves no function

A

Tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Spread of cancer beyond the primary site; tumor moves

A

Metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Depth at which electronic equilibrium occurs for photon beams; depth of maximum absorbed dose and ionizations for photons from a single treatment field, falls off after
As energy goes up, this goes further down; higher energy = lower

A

D-max

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Region between the skin surface and the depth of D-max
In this region, dose increases with depth until it reaches a maximum at the depth of D-max
The higher the x-ray energy, the greater this

A

Build-up region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dose delivered at the depth of D-max through a single treatment field; where we can calculate what is given at D-max

A
Given dose (GD)
Applied dose
D-max dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Unit of time; unit of output measure for linacs
Accelerators are calibrated so that 1 delivers 1 cGy for a standard, reference field size at a standard reference depth at a standard source-to-calibration point

A

Monitor unit (MU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

1 MU = ? cGy

A

1 cGy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Average daily dose

A

180-280 cGy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Point of intersection of the three axes of rotation of the treatment unit; gantry, couch and collimator rotate around this point in space, usually tumor

A

Isocenter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Central portion of beam emanating from the target, only part of the beam that doesn’t diverge

A

Central axis (CA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Distance from the source to the patient’s skin; disadvantage: have to move patient to make up for difference in thickness of patient

A

Source-skin distance (SSD) set-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Distance from source to the axis of rotation of the treatment unit (isocenter)

A

Source-axis distance (SAD) set-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Unblocked or open field size projected at the reference distance, usually the isocenter (100 cm)

A

Collimator field size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Equivalent rectangular field dimension of the open treatment area within the collimated field
Ex: MLCs, aperture block

A

Blocked (effective) field size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Small packet of electromagnetic energy (ex: x-rays, gamma rays, etc.)

A

Photon energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Negatively charged subatomic energy that can be accelerated by a variety of machines or emitted from decaying isotopes

A

Electron energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tool that modifies the isodose distribution of a beam to correct for tissue inhomogeneities by progressively decreasing beam intensity across the field irradiated

A

Wedge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Correct for tissue inhomogeneities

A

Compensating filter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Used to form/shape treatment field made of 50% bismuth, 26.7% lead, 13.3% tin and 10% cadmium; low melting point but toxic

A

Cerrobend block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Distinct part of a linac that allows treatment field shaping and blocking through the use of motorized leaves and the head of the machine

A

Multi-leaf collimators (MLCs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Extended metal structure used to restrict the useful beam to the required size

A

Electron application (cone)
Extension cone
Cylinder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tissue equivalent material placed on the skin to increase skin dose and even out irregular contours on the patient (similar Z to tissue)

A

Bolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Allows part of the beam to pass through while reflecting the other part of the beam; prevents beam from diverging into other part of field

A

Beamsplit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Immobilization devices created from styrofoam shell and foaming agents

A

Alpha cradle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Immobilization device that consists of a cushion and a vacuum compression pump ("beanbag")
Vac-Lok
26
Thermoplastic immobilization device; facemask
Aquaplast
27
Used to help immobilize and position tongue
Bite block
28
Lasers that project a small red or green beam of light toward the patient to set up the patient for right treatment 5: right, left, ceiling, floor, back
Positioning lasers
29
Treat patient with one field
Single field
30
Pair of fields directed along the same axis from opposite sides (ex: AP and PA)
Parallel opposed fields
31
Two oblique fields which are similar to a breast bridge, skim the field
Tangential field
32
Distance from midline to side
Breast bridge
33
Isocentric technique where the beam moves continuously about the patient
Rotation/arc therapy
34
Treatment at a short distance; uses radioactive material to deliver dose administered directly into the tumor Used in early stage disease or as a boost (ex: prostate seeds)
Brachytherapy
35
Shows distribution of absorbed dose and points of equal dose
Isodoses
36
Organs that limit the dose or dose that can be tolerated by critical structures
Critical organ dose
37
Normal tissue or vital organs whose radiation tolerance limits the deliverable dose
Critical structures
38
Normal tissues (critical structures) in which sensitivity to radiation damage may influence treatment planning and/or delivery of a prescribed dose of radiation
Organ at rise (OAR)
39
Distance between the borders of two adjacent fields, usually measured on the patient's skin; used to measure and verify the depth at which two adjacent fields abut
Gap
40
The use of imaging to compare the position of external set-up marks and internal anatomy to the treatment plan; ex: CT, portal imager (mV and/or kV), etc.
Image guided radiation therapy (IGRT)
41
Therapy that delivers non-uniform exposure across the beam's eye view (BEV) using a variety of techniques and equipment Changes dose distribution between each field; static field Inversed planned type treatment
Intensity modulated radiation therapy (IMRT)
42
Visualization perspective that is "end-on" or positioned as if looking at a volume from the source or radiation; made possible from collected CT data, this perspective is essential in three-dimensional planning
Beam's eye views (BEVs)
43
Type of specialized IMRT where it delivers radiation by rotating the radiation machine through one or more arcs while radiation is continuously delivered
Volumetric modulated arc therapy (VMAT)
44
Type of radiation therapy in which the radiation is delivered slice by slice; 6x energy Treatment unit where the linac rotates continuously while the treatment couch moves through the gantry bore producing a spiral treatment beam
Tomotherapy
45
Radiation therapy unit that accelerates electrons and produces x-rays or electron treatments
Linear accelerator (linac)
46
About 1 in ____ women will develop cancer (____ out of 100)
3; 33
47
About 1 in ____ men will develop cancer (____ out of 100)
2; 41
48
Cancer contributes to 1 out of every ____ deaths
4
49
Cancer is ________ to heart disease as the most common cause of death
2nd
50
______ deaths a day from cancer in the US
1650
51
Preventative treatment (ex: treat brain for small cell lung cancer)
Profolactic
52
Uncontrollable growth of irregular cells; will grow as long as it can Poor cell differentiation Invades other tissues (altered surface enzymes allow tumor to grow into other tissues) Grow at new sites (lymph, blood, etc.) Avoid immune system (immunotherapy) Autonomy
Cancer cell
53
Increased growth
-plasia
54
Abnormal
Dys-
55
Disorganized growth
Dysplasia
56
Increased, excessive
Hyper-
57
Quality or state of being self-governing; self-directing freedom, especially moral independence No limitations of growth
Autonomy
58
Tumors that often invade and destroy normal surrounding tissue and, if left untreated, can cause the death of the host Have no purpose and immortal
Malignant
59
Increased cellularity (number of cells increase)
Hyperplasia
60
After
Meta-
61
Abnormal appearing of cells, start seeing different cells in an area; not counted as malignant (ex: Barrett's esophagus)
Metaplasia
62
More
Pleo-
63
Variance in size and shape of cells
Pleomorphism
64
Cell looks the same as the cell it originated from
Well differentiation
65
Cell looks unlike cell it originated from; more sensitive to radiation
Poor differentiation/anaplastic
66
2 types of exposure to carcinogens
Incomplete | Complete
67
Requires same cell to be affected by promoter, can't cause cancer on its own (ex: UV light, hormones, etc.)
Incomplete exposure
68
Directly causes cancer (ex: chemicals, viruses, environment)
Complete exposure
69
3 stage theory of carcinogens
Initiation Promotion Progression
70
4 stages of cell growth
Initiation Promotion Progression Metastasis
71
Altered DNA cell leads to mutation
Initiation
72
Promoting agent enhances faulty DNA (preneoplastic to neoplastic)
Promotion
73
New growth of tumor cell (neoplasm)
Progression
74
Cell growth, spreads from one point to another
Metastasis
75
Study of the causes of disease
Etiology
76
Controls cellular division of normal calls; can become oncogen
Protooncogenes
77
Gene that regulates the development and growth of cancerous tissues; on/off switch of cancer cells
Oncogene
78
Gene whose presence and proper function produces normal cellular growth and division; absence or inactivation of such a gene lease to uncontrolled growth Arrest the damaged DNA to give it time to repair itself
Tumor-suppressor gene
79
New growth
Neoplasia
80
Provides information about its biological aggressiveness and is based on the degree of cell differentiation
Grade
81
Cancers grow by reproducing cells; completes cell cycle by loses restriction at ________
G0 (resting phase)
82
Time it takes for tumor to double in size (can be hours to months)
Doubling time
83
Earliest cancer can be detected on x-ray
30 doublings will reach 1 cm in size (about size of a marble)
84
_____ more doublings past 30 can lead to death
10
85
Change in ________ can help detect cancer early
WBC count
86
Greatest risk of developing cancer
Age
87
Multiple types of cells in tumor volume with a different response to radiation Tumors are not just one type of cell
Tumor heterogeneity
88
5 ways cancers metastasize
Enter blood and lymph vessels (most common) Invasion of adjacent tissues, continuously growing Invasion/evasion of immune system Reentrance into distant tissue Implantation of malignant cells in new tissue
89
Implantation of malignant cells in new tissue The spillage of tumor cell clusters and their subsequent growth as malignant implants at a site adjacent to an original tumor Can happen during surgery (tumor removed and part left or falls off somewhere else and grows)
Seeding
90
Cancer cells break away from tumor and disseminate in blood
Intravasation
91
Certain cancer cells go to certain sites (ex: prostate to bone)
Homing
92
Process by which vascular networks (blood supply) are created to sustain malignant tumors
Angiogenesis/neovascularization
93
Metastasis = stage ?
4 (highest, poor prognosis)
94
4 common metastatic sites (most to least common) of lung cancer
Liver Adrenal glands Bone Brain
95
4 common metastatic sites (most to least common) of breast cancer
Lymph Bone Lung Liver
96
Common metastatic site of stomach cancer
Liver
97
2 common metastatic sites (most to least common) of anus cancer
Liver | Lungs
98
3 common metastatic sites (most to least common) of bladder cancer
Lungs Bone Liver
99
3 common metastatic sites (most to least common) of prostate cancer
Bone Liver Lungs
100
3 common metastatic sites (most to least common) of uterine cervix cancer
Lungs Bone Liver
101
Common metastatic site of colon cancer
Liver (direct hepatic drainage)
102
Common metastatic site of sarcomas
Lungs
103
3 patterns of cancer occurrence
Sporadic Inherited Familial cancer
104
Most cancers arise spontaneously (most common pattern of occurrence; no history or exposure to carcinogens Occurs later in life (greater than 50 years)
Sporadic
105
Family has pattern of cancer, patient inherited faulty repair gene Rare (less than 10% of all cancer) Typically occur at younger age/earlier in life Requires promoter, bilateral Ex: breast cancer about 5%
Inherited
106
Certain cancers happen enough that it can't be related to chance but is not genetic Families share certain risk factors (ex: smoke, diet) and environment Occurs later in life
Familial cancer
107
Between ____% to _____% of all cancers are associated with lifestyle (ex: smoking and diet)
60% to 70%
108
Most preventable cause of cancer
Cigarette smoking
109
3 patterns of cancer occurance
Sporadic Inherited Familial cancer
110
Most cancers arise spontaneously, no history or exposure to carcinogens; occurs later in life (greater than 50 years)
Sporadic
111
Family has pattern of cancer, patient inherited faulty repair gene; two or more generations diagnosed with the same or related forms of cancer Rare, less than 10% of all cancers Typically occurs at younger age/earlier in life Requires promotor Usually bilateral, multifocal, or multiple primary tumors in one or more family members Ex: about 5% of breast cancer
Inherited
112
Certain cancers happen enough that it can't be related to chance but it's not genetic Families share certain risk factors (ex: smoke, diet) and environment Occurs later in life
Familial cancer
113
Between ____% to ____% of all cancers are associated with lifestyle (ex: smoking, diet)
60% to 70%
114
Most preventable cause of cancer; ____% of lung cancer in men, ____% in women
Cigarette smoking; 90%, 70%
115
Occurance of cancer in the general population
Absolute risk
116
Statistical estimate that compares the likelihood of development of a cancer in a person who has a specific risk factor with the likelihood in a person who doesn't have the specific risk factor Risk of someone developing disease with a risk factor compared to someone without the risk factor
Relative risk
117
Number of cases of cancer that could be prevented with the manipulation of known risk factors Amount of disease caused by a specific risk factor and its prevention if changed within the population
Attributable risk
118
7 cancers smoking is associated with
``` Head and neck Stomach Bladder Kidney Pancreas Liver Cervix ```
119
___% to ___% of all hereditary cancers diagnosed
5% to 10%
120
Cancer on both sides of the body (ex: kidneys, breasts)
Bilateral
121
Cancer in different spots, more aggressive
Multifocal
122
Noma
Tumor
123
Leio
Smooth
124
Myo
Muscle
125
Sarcoma
Connective tissue
126
Hemato
Blood
127
Neuro
Nervous system (brain)
128
Adeno
Glandular
129
Carcinoma
Epithelium
130
Classification of benign and malignant tumors of glandular epithelium
Benign: adenoma Malignant: adenocarcinoma
131
Classification of benign and malignant tumors of squamous epithelium
Benign: papilloma Malignant: squamous cell carcinoma
132
The thin tissue forming the outer layer of a body's surface and lining the alimentary canal and other hollow structures
Epithelium
133
Relating to, consisting of, or denoting a layer of epithelium that consists of very thin flattened cells
Squamous
134
Classification of benign and malignant tumors of connective tissue smooth muscle
Benign: leiomyoma Malignant: leiomyosarcoma
135
Classification of malignant tumors of the hematopoietic system
Leukemia (WBC)
136
Classification of malignant tumors of the lymphoreticular system
Lymphoma
137
Classification of benign and malignant tumors of the neural system
Benign: neuroma Malignant: blastoma
138
Most common histology associated with the oral cavity, pharynx, lung, anus, and cervix (tissue comes in direct contact with carcinogen)
Squamous cell carcinoma
139
Most common histology associated with the breast
Infiltrating ductal carcinoma
140
Most common histology associated with the colon and rectum, endometrium, and prostate (gland)
Adenocarcinoma
141
Most common histology associated with the brain
Astrocytoma
142
3 levels of cancer prevention
Primary Secondary Tertiary
143
Evading disease by methods such as immunization, avoiding tobacco, and reducing exposure to UV light
Primary cancer prevention
144
Early detection and treatment of subclinical, asymptomatic, or early disease in persons without signs or symptoms of cancer Screenings should be sensitive (disease present) and specific (no disease) and take into account false positives and negatives
Secondary cancer prevention
145
Management of an illness to prevent progression, recurrence, or other complications (ex: blood test)
Tertiary cancer prevention
146
5 dietary recommendations to reduce cancer risk
Avoid overeating, maintain ideal body weight (ex: fat cells produce estrogen associated with breast cancer) Reduce fat intake to less than 30% of total caloric intake Eat fruits and vegetables that provide fiber (5 servings a day); decreases transfer time of fecal material, provides antioxidants Minimize the intake of foods that are salt-cured, smoked (associated with stomach and esophageal cancer), and nitirite-cured (ex: lunch meat, bacon); food preservatives (nitrates and nitrites) associated with increased risk of cancer Limit consumption of alcoholic beverages/don't drink excessively (oral cavity, larynx, esophagus, breast, and liver cancer)
147
Number of new cases per 100,000 people per year
Incidence rate
148
Number of deaths per 100,000 people per year
Mortality rate
149
Proportion of patients alive at some point after their diagnosis
Survival rate
150
The number of cancers that exist in a defined population at a given point in time Measures proportion of the population who have cancer at a specified point or during an interval of time; how common it is seen in population
Prevalence
151
Include fatality rates only for those who have the disease
Case-fatality rate
152
Most common cancer in both men and women
Skin cancer (basal, squamous, malignant melanomas
153
3 most common cancers in men (account for 41% of all cancers in men)
Prostate Lung and bronchus Colon and rectum
154
3 incidence rates of cancer in men
Black men have the highest incidence White men are next American Indians/Alaska Natives had the lowest rates
155
3 most common cancers in women (account for 50% of all cancers in women)
Breast (30%) Lung and bronchus Colon and rectum
156
How long you can stay in the sun without getting burned x SPF number
Sun protection factor (SPF)
157
Second leading cause of death in the US
Lung cancer
158
5 incidence rates of cancer in women
``` White women have the highest rates Blacks Hispanics Asian/Pacific Islander American Indian/Alaska Native women have the lowest rates ```
159
5 tests recommended for colorectal screenings by the American Cancer Society (ACS) and how often they should be done
Fecal occult blood test (FOBT)- look for blood in feces by getting a stool sample on a test card coated with a plant based substance called guaiac; annual Flexible sigmoidoscopy (flex sig) every 5 years Double contrast BE every 5 years Colonoscopy every 10 years or virtual CT colonoscopy every 5 years (can't biopsy) Combination of FOBT and flex sig every 5 years
160
When does the ACS recommend people should begin colorectal screenings?
Start around 50 years old or 40-45 if high risk
161
3 ACS recommendations for breast cancer screenings
Breast self-examinations (BSE) Clinical breast examinations Mammography (40 years and older)
162
When does the ACS recommend people should do BSEs?
Start at age 20 and perform monthly 5-7 days after period; lead to a lot of false positives so now recommend be familiar with breast
163
When does the ACS recommend people should get clinical breast exams?
Start at 20 years old every 4 years until annually at 40 years old
164
When does the ACS recommend people should get mammograms at 40-44 years old, 45-54, and older than 55?
40-44: up to patient 45-54: annually Older than 55: every 2 years
165
Mammography benefits older women ___ to ___ years old; reduce mortality by ____% to ____% at this age
50-69 years old | 20% to 35%
166
5 risk factors of breast cancer
``` Mother or sister had premenopausal or bilateral disease Had period before age 12 Reached menopause after age 55 First birth after 30 years old Nulliparity ```
167
Never given birth
Nulliparity
168
3 components of BSEs
Visual examination in mirror (scaling or dimpling, change in nipple, discharge) Palpation in the shower Palpation in the supine position on the bed
169
Blood test, indicators that increase or come about because person has cancer
Serum tumor markers
170
Cancer protein/molecule immune system recognizes
Cancer antigen (CA)
171
7 serum tumor markers
``` Alpha-fetoprotein (AFP) Carcinoembryonic antigen (CEA) CA-125 CA-15-3 CA 19-9 Human chorionic gonadotropin Prostate-specific antigen (PSA) ```
172
4 cancers associated with AFP
Hepatocellular carcinoma Choriocarcinoma (uterus) Teratoma Tumors of testes and ovaries
173
7 cancers associated with CEA
``` Colon Rectum Pancreas Stomach Lung Breast Ovary ```
174
3 cancers associated with CA-125
Ovarian Breast Colorectal
175
Cancer associated with CA-15-3
Breast
176
4 cancers associated with CA 19-9
Colorectal Pancreas Stomach Liver
177
4 cancers associated with HCG
Choriocarcinomas Germ cell tumors Testicular disease Hydidiform moles (cysts) - hormonal reproductive system
178
Structure, shape, etc.
Morphology
179
Cell type
Histology
180
Surgical procedure that involves removing all or part of the tissue suspected of being cancerous
Biopsy
181
4 biopsies from smallest to largest
Needle Incisional Excisional Open
182
2 types of needle biopsies
Aspiration | Core
183
Smallest biopsy, cytological sample
Aspiration
184
Insert needle and remove tumor cells
Core
185
Act of cutting into tissue to remove part of the tumor so that a diagnosis can be made, larger than needle
Incisional
186
Removal of the entire tumor by cutting it out so that a diagnosis can be made
Excisional
187
Under direct vision or by laser remove part or whole tumor, most invasive
Open biopsy
188
Why is pathology important?
A clinical diagnosis is just a guess without a pathology report
189
3 things neede to identify the histopathology
Tumor type Classification Grade
190
Tumor type
Origin
191
Subtype of malignancy (ex: adenosquamous)
Classification
192
Provides information about a tumor's biologic aggressiveness and is based on the degree of cell differentiation (what cell looks like)
Grade
193
Few features of cell tumor originated from = high grade tumor
Poorly undifferentiated
194
Higher grade tumor = _____ aggressive
More aggressive
195
5 grades (G) for malignancy
``` X I (1) II (2) III (3) IV (4) ```
196
Grade cannot be determined, not enough information
GX
197
Cells are well differentiated, closely resembling the tissue from which they arose; considered a low-grade tumor Mature cells
GI (1)
198
Cells are moderately differentiated; still resemble normal cells somewhat, but exhibit more malignant characteristics Cells have some immaturity and vary from normal tissue
GII (2)
199
Cells are poorly differentiated; few normal cellular characteristics are retained, but the tissue of origin may still be established Immature cells, do not look like normal cells
GIII (3)
200
Cells are undifferentiated, no normal cellular characteristics can be found and determining the origin is very difficult
GIV (4)
201
3 steps in which cancer is staged
Start with history and physical (H&P) - background (ex: smoker, drinker), family history, when signs and symptoms started if any Order radiographic procedures, diagnostic tests (radiation oncologist = administers RT; medical oncologist = chemotherapy doctor) Order with some labs (easy way to get a lot of information from patient)
202
Step-by-step process to determine the size and location of a tumor and the degree to which it has spread
Staging
203
The movement of charged particles in a fluid or gel under the influence of an electric field
Electrophoresis
204
Staging system from the American Joint Committee on Cancer (AJCC) used on solid tumors (breast, lung, colon, etc.)
Tumor-node-metastasis (TNM) staging
205
Characteristics of a given tumor (size, depth of invasion, involvement of surrounding structures)
Tumor (T)
206
Presence or absence of involved nodes and size or number of involved nodes
Node (N)
207
Presence or absence of metastasis
Metastasis (M)
208
4 stages of the primary tumor (T)
TX T0 Tis T1, T2, T3, T4
209
Primary tumor cannot be assesed
TX
210
No evidence of primary tumor
T0
211
Carcinoma in situ
Tis
212
An early form of cancer defined by the absence of invasion
In situ
213
Increasing size and/or local extent of the primary tumor specific to every disease
T1, T2, T3, T4
214
3 stages of regional lymph nodes (N)
NX N0 N1, N2, N3
215
Regional lymph nodes cannot be assessed
NX
216
No regional lymph node metastasis
N0
217
Increasing involvement of regional lymph nodes
N1, N2, N3
218
3 stages of distant metastasis
MX M0 M1
219
Distant metastasis cannot be assesd
MX
220
No distant metastasis
M0
221
Distant metastasis
M1 (automatically stage 4)
222
3 reasons staging is important
Gives prognosis values Determines treatment based on disease within the patient Data collection gives protocols for type of disease and what treatment works best for it; tumor registry
223
Database tracking mechanism for cancer incidence, characteristics, management, and results in cancer treatment facilities for patients diagnosed with cancer; carry diagnosis, stage, and treatment Follow patient for life through followup examinations
Tumor registry
224
4 stages of the Ann Arbor classification of lymphoma staging (Hodgkin's) (spreads in a pattern)
Stage I Stage II Stage III Stage IV
225
Lymphoma confined to nodal group
Stage I
226
More than one group of lymphoma on the same side of the diaphragm
Stage II
227
Lymphoma on both sides of the diagram
Stage III
228
Disseminated disease, spread of lymphoma
Stage IV
229
Fevers, night sweats, and weight loss from lymphoma
B-symptoms
230
Extra lymphatic disease (extra nodal site with disease)
E
231
5 stages of leukemia using the Rai system
``` Stage 0 Stage I Stage II Stage III Stage IV ```
232
The Rai staging system works well with what leukemia?
Chronic lymphocytic leukemia (CLL)
233
Rai stage of leukemia where patient has more than 10,000 lymphocytes
Stage 0
234
Rai stage of leukemia where patient has enlarged lymph nodes
Stage I
235
Rai stage of leukemia where patient has enlarged liver and/or spleen
Stage II
236
Rai stage of leukemia where patient has anemia
Stage III
237
Rai stage of leukemia where patient has thrombocytopenia
Stage IV
238
Decrease in the peripheral red cell count, low RBCs
Anemia
239
Abnormal decrease in the number of platelets
Thrombocytopenia
240
About ___% to ___% of all acute lymphoblastic leukemia (ALL) will achieve complete remission and ____% to ____% will be cured; ____% to ____% cure rate for kids
About 80% to 90% of all acute lymphoblastic leukemia (ALL) will achieve complete remission and 30% to 40% will be cured; 60% to 80% cure rate for kids
241
Most common childhood leukemia
ALL
242
3 stages of the Binet classification of leukemia
Clinical stage A Clinical stage B Clinical stage C
243
Binet stage of leukemia where patient has no anemia or thrombocytopenia and less than three areas of lymphoid involvement
Clinical stage A
244
Binet stage of leukemia where patient has no anemia or thrombocytopenia with greater than or equal to three areas of lymphoid involvement
Clinical stage B
245
Binet stage of leukemia where patient has anemia and/or thrombocytopenia regardless of the number of lymphoid enlargement
Clinical stage C
246
4 stages of colon cancer according to Dukes staging system
A B C D
247
Colon cancer confined to muscular lining of bowel wall
A
248
Colon cancer grown beyond muscular layer of bowel wall
B
249
Colon cancer spread to involved lymph nodes
C
250
Distant metastasis of colon cancer
D
251
Staging system for how deeply penetrating a melanoma is
Clark and Breslow
252
7 other tests for cancer
``` CT: general anatomic information MRI: soft tissue (ex: brains) Nuclear medicine: bone scans, physiological PET: changed lung disease treatment PET/CT Bone marrow biopsy: through iliac crest Multiple gated acquisition (MUGA) scan ```
253
Scan that determines heart function using a gamma camera; restrictions to who can be around patient (ex: pregnant, kids)
Multiple gated acquisition (MUGA) scan
254
5 advantages of PET/CT
``` Concise calibration Patient in same position Good for lymphomas Check response to chemotherapy Check for recurrent disease ```
255
Patients that have mets Tests show no obvious origin (undifferentiated cells) Prognosis around 3-4 months
Unknown primary
256
Unknown primaries account for what percent of all cancers?
5-10%
257
Must have _________________ to determine if someone has cancer
Tissue diagnosis
258
3 steps needed to complete staging
Diagnosis Prognosis Correct treatment
259
How often should we check a patient's blood?
Once a week
260
WBCs less than ______ stops treatment, increased risk of infection
2,000
261
Platelets less than _______ may stop treatment; below ______ to ______ at risk for severe bleed
Platelets less than 100,000 may stop treatment; below 20,000 to 50,000 at risk for severe bleed
262
Percent of packed RBC
Hematocrit (HCT)
263
Normal HCT level, in men, and in women
``` Normal = 40-45% Men = 38.8-46.4% Women = 35.4-44.4% ```
264
What transports oxygen in blood
Iron
265
Iron level
Hemoglobin (HGB)
266
Normal HGB level in men, women, and children (g/dL)
``` Men = 13.3-16.2 g/dL Women = 12-15.8 g/dL Children = 11.5-14.5 g/dL ```
267
Normal erythrocyte (RBC) blood counts per cubic millimeter and percentage for men and women
Men per cubic millimeter = 4.3-5.6 x 10^6; percentage = 100 | Women per cubic millimeter = 4-5.2 x 10^6; percentage = 100
268
Normal reticulocyte blood count per cubic millimeter and percentage
Per cubic millimeter = 0.8-2.3% red cells | Percentage = 100
269
Normal total leukocyte (WBC) blood count per cubic millimeter and percentage
Per cubic millimeter = 3,500-9,050 | Percentage = 100
270
Normal band blood count per cubic millimeter and percentage
Per cubic millimeter = 0-450 | Percentage = 0-5
271
Normal lymphocyte blood count per cubic millimeter and percentage
Per cubic millimeter = 701-4,530 | Percentage = 20-50
272
Normal eosinophil blood count per cubic millimeter and percentage
Per cubic millimeter = 0-540 | Percentage = 0-6
273
Normal basophil blood count per cubic millimeter and percentage
Per cubic millimeter = 0-180 | Percentage = 0-2
274
Normal monocyte blood count per cubic millimeter and percentage
Per cubic millimeter = 140-720 | Percentage = 4-8
275
Normal platelet blood count per cubic millimeter
165,000-415,000 per cubic millimeter (severely low less than 20,000)
276
Clotting factor
Platelets
277
Bone marrow aspiration/biopsy detects or assesses
Hematologic abnormalities
278
Blood chemistries and hepatic function studies detects or assesses
Abnormalities of the liver, kidneys, and bone related to cancer or its therapy
279
Complete blood count detects or assesses
Bone marrow abnormalities or treatment toxicity
280
Creatinine clearance detects or assesses
Kidney function, especially important prior to administration for nephrotoxic drugs
281
Hemoccult test detects or assesses
Presence of blood in stool; screening but not specific for cancer
282
Pap smear detects or assesses
Cervical cancer or premalignant changes
283
Serum electrophoresis detects or assesses
Serum protein and immunoglobulin levels (multiple myeloma)
284
Urine catecholamines detects or assesses
Neuroblastoma, pheochromocytoma (released by adrenals)